Home » Topics » Regulatory » EMA

EMA
RSS

AMAG and Takeda begin global registrational program of ferumoxytol

July 1, 2010

EMA's CHMP issues positive opinion for Pharming's Rhucin

June 29, 2010

CHMP recommends approval of vernakalant for atrial fibrillation

June 29, 2010

CHMP confirms previous negative opinion for ceftobiprole

June 29, 2010

CHMP recommends approval of Sycrest for bipolar disorder

June 29, 2010

CHMP recommends approval of Shire's VPRIV for type 1 GD

June 29, 2010

Pharmaxis reports on second phase III trial of Bronchitol in CF

June 23, 2010

EC grants orphan status to pralatrexate for cutaneous T-cell lymphoma

June 21, 2010

OBI-1 obtains positive opinion for orphan drug status in Europe

June 18, 2010

EMA approves update to bortezomib label for multiple myeloma

June 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...